skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 44,599  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Lung Neoplasms - Pathology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Single-cell spatial landscapes of the lung tumour immune microenvironment
Material Type:
Article
Add to My Research

Single-cell spatial landscapes of the lung tumour immune microenvironment

Nature (London), 2023-02, Vol.614 (7948), p.548-554 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Feb 16, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05672-3 ;PMID: 36725934

Full text available

2
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Material Type:
Article
Add to My Research

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285 [Peer Reviewed Journal]

2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.18.01585 ;PMID: 30550363

Full text available

3
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
Material Type:
Article
Add to My Research

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

PloS one, 2013-03, Vol.8 (3), p.e60317-e60317 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;2013 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Chen et al 2013 Chen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0060317 ;PMID: 23555954

Full text available

4
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Material Type:
Article
Add to My Research

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Nature communications, 2015-03, Vol.6 (1), p.6377-6377, Article 6377 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 2015 ;Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms7377 ;PMID: 25758528

Full text available

5
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 + T cell exhaustion
Material Type:
Article
Add to My Research

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 + T cell exhaustion

Nature communications, 2020-09, Vol.11 (1), p.4520-4520, Article 4520 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18298-8 ;PMID: 32908154

Full text available

6
Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer
Material Type:
Article
Add to My Research

Adjuvant chemotherapy for resected early‐stage non‐small cell lung cancer

Cochrane database of systematic reviews, 2015-03, Vol.2015 (3), p.CD011430-CD011430 [Peer Reviewed Journal]

Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;ISSN: 1469-493X ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011430 ;PMID: 25730344

Full text available

7
Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer
Material Type:
Article
Add to My Research

Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer

PloS one, 2012-04, Vol.7 (4), p.e35065-e35065 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Lv et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Lv et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0035065 ;PMID: 22493729

Full text available

8
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Material Type:
Article
Add to My Research

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

The lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Jan 1, 2018 ;2018. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30729-5 ;PMID: 29174310

Full text available

9
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1655-1669 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30634-5 ;PMID: 31591063

Full text available

10
The evolution of lung cancer and impact of subclonal selection in TRACERx
Material Type:
Article
Add to My Research

The evolution of lung cancer and impact of subclonal selection in TRACERx

Nature (London), 2023-04, Vol.616 (7957), p.525-533 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Apr 20, 2023 ;The Author(s) 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-023-05783-5 ;PMID: 37046096

Full text available

11
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709937 ;PMID: 28885881

Full text available

12
Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
Material Type:
Article
Add to My Research

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer

PloS one, 2021-12, Vol.16 (12), p.e0260988-e0260988 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Rice, Belani. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Rice, Belani 2021 Rice, Belani ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0260988 ;PMID: 34855926

Full text available

13
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Material Type:
Article
Add to My Research

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.1211-1228 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2019 ;Copyright © 2019, American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci123319 ;PMID: 30589644

Full text available

14
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
Material Type:
Article
Add to My Research

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer

British journal of cancer, 2019-09, Vol.121 (6), p.490-496 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0541-3 ;PMID: 31388183

Full text available

15
Metformin use and lung cancer survival: a population-based study in Norway
Material Type:
Article
Add to My Research

Metformin use and lung cancer survival: a population-based study in Norway

British journal of cancer, 2021-03, Vol.124 (5), p.1018-1025 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01186-9 ;PMID: 33262518

Full text available

16
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801005 ;PMID: 29658856

Full text available

17
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to My Research

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy275 ;PMID: 30285222

Full text available

18
Emerging therapeutic agents for advanced non-small cell lung cancer
Material Type:
Article
Add to My Research

Emerging therapeutic agents for advanced non-small cell lung cancer

Journal of hematology and oncology, 2020-05, Vol.13 (1), p.58-58, Article 58 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-020-00881-7 ;PMID: 32448366

Full text available

19
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-02, Vol.388 (6), p.489-498 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212083 ;PMID: 36780674

Full text available

20
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Material Type:
Article
Add to My Research

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Annals of oncology, 2019-10, Vol.30 (10), p.1653-1659 [Peer Reviewed Journal]

2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz288 ;PMID: 31435660

Full text available

Results 1 - 20 of 44,599  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (41,176)

Refine My Results

Creation Date 

From To
  1. Before 1969  (139)
  2. 1969 To 1981  (982)
  3. 1982 To 1994  (3,226)
  4. 1995 To 2008  (10,859)
  5. After 2008  (29,402)
  6. More options open sub menu

Language 

  1. English  (42,959)
  2. Japanese  (8,055)
  3. Chinese  (648)
  4. French  (401)
  5. German  (305)
  6. Spanish  (190)
  7. Portuguese  (156)
  8. Polish  (81)
  9. Russian  (45)
  10. Turkish  (36)
  11. Norwegian  (31)
  12. Italian  (11)
  13. Korean  (11)
  14. Hungarian  (10)
  15. Serbian  (9)
  16. Icelandic  (8)
  17. Czech  (6)
  18. Ukrainian  (5)
  19. Croatian  (5)
  20. Swedish  (3)
  21. More options open sub menu

Searching Remote Databases, Please Wait